2 results
Approved WMORecruiting
The primary objective of the SPIRIT*HF study is to compare Spironolactone to Placebo in reducing the rate…
Approved WMOCompleted
* Primary Objective:To assess the effect of MEDI0382 on hepatic glycogen levels versus placebo after 28 days (Part A) and 35 days (Part B) of treatment* Secundary Objective: - To assess the effect of MEDI0382 on hepatic glycogen levels versus…